{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:30Z","timestamp":1787024670439,"version":"build-2736575974"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Breast cancer (BC) is the second-leading cause of cancer-related fatalities\nin women after lung cancer worldwide. The development of BC is significantly influenced by estrogen\nreceptors (ERs). The problem with current cancer treatments is selectivity, target specificity,\ncytotoxicity, and developing resistance. Thiazole scaffolds are gaining popularity in drug discovery\ndue to their broad range of biological activity. It has the extraordinary capacity to control a\nvariety of cellular pathways, and its potential for selective anticancer activity can be explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Synthesis and in-silico studies of 4-Phenyl thiazol-2-amine derivatives as anti-breast\ncancer agents and molecular docking was used to assess the compounds\u2019 capacity to bind ER-\u03b1\nprotein target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, 4-Phenylthiazol-2-amine derivatives (3a-j) have been synthesized, and\nusing Schrodinger software, molecular docking and ADME studies of the compounds were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most of the synthesized compounds have shown dock scores ranging from -6.658 to -\n8.911 kcal\/mol, which is better than the standard drug tamoxifen (-6.821 kcal\/mol). According to\nmolecular docking, all compounds fit in the protein\u2019s active site and have the same hydrophobic\npocket as the standard drug tamoxifen. Further, all of the compounds\u2019 ADME properties are below\nacceptable limits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Compound 3e showed the best docking score of -8.911. All compounds\u2019 ADME\nproperties are within acceptable limits, and their p\/o coefficients fall within a range, suggesting\nthey will all have sufficient absorption at the site of action. These compounds can be evaluated invitro\nand in-vivo in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573409919666230321145543","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:07:51Z","timestamp":1679443671000},"page":"374-383","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis and in-silico Studies of 4-phenyl thiazol-2-amine Derivatives as\nPutative Anti-breast Cancer Agents"],"prefix":"10.2174","volume":"20","author":[{"given":"Kanamarlapudi Joshna","family":"Lavanya","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab,\n151401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab,\n151401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Jaitak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab,\n151401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.4155\/fmc-2018-0416","volume":"11","author":"Ayati A.","year":"2019","unstructured":"Ayati A.; Emami S.; Moghimi S.; Foroumadi A.; Thiazole in the targeted anticancer drug discovery. Future Med Chem 2019,11(15),1929-1952","journal-title":"Future Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel R.L.","year":"2022","unstructured":"Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2022. CA Cancer J Clin 2022,72(1),7-33","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"Uhlen M.","year":"2017","unstructured":"Uhlen M.; Zhang C.; Lee S.; Sj\u00f6stedt E.; Fagerberg L.; Bidkhori G.; Benfeitas R.; Arif M.; Liu Z.; Edfors F.; Sanli K.; von Feilitzen K.; Oksvold P.; Lundberg E.; Hober S.; Nilsson P.; Mattsson J.; Schwenk J.M.; Brunnstr\u00f6m H.; Glimelius B.; Sj\u00f6blom T.; Edqvist P.H.; Djureinovic D.; Micke P.; Lindskog C.; Mardinoglu A.; Ponten F.; A pathology atlas of the human cancer transcriptome. Science 2017,357(6352),eaan2507","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0975-5950.102155","volume":"3","author":"Dandriyal R.","year":"2012","unstructured":"Dandriyal R.; Pandit N.; Rao S.C.; Sapra G.; Sharma H.; Agarwal U.; Psammomatoid juvenile aggressive ossifying fibroma of mandible. Natl J Maxillofac Surg 2012,3(1),47-50","journal-title":"Natl J Maxillofac Surg"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","volume":"93","author":"Li C.I.","year":"2005","unstructured":"Li C.I.; Uribe D.J.; Daling J.R.; Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005,93(9),1046-1052","journal-title":"Br J Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13058-015-0546-7","volume":"17","author":"Dossus L.","year":"2015","unstructured":"Dossus L.; Benusiglio P.R.; Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 2015,17(1),37","journal-title":"Breast Cancer Res"},{"key":"ref=7","author":"Blowman K.","year":"2018","unstructured":"Blowman K.; Magalh\u00e3es M.; Lemos M.; Cabral C.; Pires I.; Anticancer properties of essential oils and other natural products. Evid Based Complement Altern Med, 2018 2018","journal-title":"Evid Based Complement Altern Med, 2018"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"Patel H.K.","year":"2018","unstructured":"Patel H.K.; Bihani T.; Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther 2018,186,1-24","journal-title":"Pharmacol Ther"},{"key":"ref=9","first-page":"1437","volume":"9","author":"Martinkovich S.","year":"2014","unstructured":"Martinkovich S.; Shah D.; Planey S.L.; Arnott J.A.; Selective estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging 2014,9,1437-1452","journal-title":"Clin Interv Aging"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jsbmb.2010.06.012","volume":"122","author":"Foryst-Ludwig A.","year":"2010","unstructured":"Foryst-Ludwig A.; Kintscher U.; Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 2010,122(1-3),74-81","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","volume":"29","author":"Jia M.","year":"2015","unstructured":"Jia M.; Dahlman-Wright K.; Gustafsson J.\u00c5.; Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab 2015,29(4),557-568","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.mce.2015.01.016","volume":"418","author":"Anbalagan M.","year":"2015","unstructured":"Anbalagan M.; Rowan B.G.; Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer. Mol Cell Endocrinol 2015,418(Pt 3),264-272","journal-title":"Mol Cell Endocrinol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2225-4110(16)30082-7","volume":"2","author":"Lee J.Y.","year":"2012","unstructured":"Lee J.Y.; Kim H.S.; Song Y.S.; Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med 2012,2(2),96-104","journal-title":"J Tradit Complement Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/jnci\/93.19.1449","volume":"93","author":"Jordan V.C.","year":"2001","unstructured":"Jordan V.C.; Gapstur S.; Morrow M.; Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 2001,93(19),1449-1457","journal-title":"J Natl Cancer Inst"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1056\/NEJMra022219","volume":"348","author":"Riggs B.L.","year":"2003","unstructured":"Riggs B.L.; Hartmann L.C.; Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003,348(7),618-629","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14656566.2019.1615882","volume":"20","author":"Yavropoulou M.P.","year":"2019","unstructured":"Yavropoulou M.P.; Makras P.; Anastasilakis A.D.; Bazedoxifene for the treatment of osteoporosis. Expert Opin Pharmacother 2019,20(10),1201-1210","journal-title":"Expert Opin Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejmech.2017.07.042","volume":"142","author":"Singh A.K.","year":"2017","unstructured":"Singh A.K.; Raj V.; Saha S.; Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions. Eur J Med Chem 2017,142,244-265","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/1573409916666200628104638","volume":"17","author":"Dandriyal J.","year":"2021","unstructured":"Dandriyal J.; Kaur K.; Jaitak V.; Synthesis and in silico studies of c-4 substituted coumarin analogues as anticancer agents. Curr Computeraided Drug Des 2021,17(4),560-570","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ejmech.2015.04.015","volume":"97","author":"Ayati A.","year":"2015","unstructured":"Ayati A.; Emami S.; Asadipour A.; Shafiee A.; Foroumadi A.; Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur J Med Chem 2015,97,699-718","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00044-011-9685-2","volume":"21","author":"Kashyap S.J.","year":"2012","unstructured":"Kashyap S.J.; Garg V.K.; Sharma P.K.; Kumar N.; Dudhe R.; Gupta J.K.; Thiazoles: having diverse biological activities. Med Chem Res 2012,21(8),2123-2132","journal-title":"Med Chem Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ejmech.2014.10.058","volume":"97","author":"Rouf A.","year":"2015","unstructured":"Rouf A.; Tanyeli C.; Bioactive thiazole and benzothiazole derivatives. Eur J Med Chem 2015,97,911-927","journal-title":"Eur J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/jhet.2827","volume":"54","author":"Mishra R.","year":"2017","unstructured":"Mishra R.; Sharma P.K.; Verma P.K.; Tomer I.; Mathur G.; Dhakad P.K.; Biological potential of thiazole derivatives of synthetic origin. J Heterocycl Chem 2017,54(4),2103-2116","journal-title":"J Heterocycl Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.2174\/0929867329666220318100019","volume":"29","author":"Jaitak V.","year":"2022","unstructured":"Jaitak V.; Sahil; Kaur, K. Thiazole and related heterocyclic systems as anticancer agents: A review on synthetic strategies, mechanisms of action and SAR studies. Curr Med Chem 2022,29(29),4958-5009","journal-title":"Curr Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"112016","DOI":"10.1016\/j.ejmech.2019.112016","volume":"188","author":"Sharma P.C.","year":"2020","unstructured":"Sharma P.C.; Bansal K.K.; Sharma A.; Sharma D.; Deep A.; Thiazole-containing compounds as therapeutic targets for cancer therapy. Eur J Med Chem 2020,188,112016","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1248\/cpb.c19-00681","volume":"67","author":"El-Mawgoud H.K.A.","year":"2019","unstructured":"El-Mawgoud H.K.A.; Synthesis, in-vitro cytotoxicity and antimicrobial evaluations of some novel thiazole based heterocycles. Chem Pharm Bull 2019,67(12),1314-1323","journal-title":"Chem Pharm Bull"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1016\/j.ejmech.2009.04.019","volume":"44","author":"Liu X.H.","year":"2009","unstructured":"Liu X.H.; Lv P.C.; Xue J.Y.; Song B.A.; Zhu H.L.; Novel 2,4,5-trisubstituted oxazole derivatives: Synthesis and antiproliferative activity. Eur J Med Chem 2009,44(10),3930-3935","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e0174006","DOI":"10.1371\/journal.pone.0174006","volume":"12","author":"Sun M.","year":"2017","unstructured":"Sun M.; Xu Q.; Xu J.; Wu Y.; Wang Y.; Zuo D.; Guan Q.; Bao K.; Wang J.; Wu Y.; Zhang W.; Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity. PLoS One 2017,12(3),e0174006","journal-title":"PLoS One"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.19261\/cjm.2006.01(1).10","volume":"1","author":"Macaev F.","year":"2006","unstructured":"Macaev F.; What can be done with the acetyl group of aryl-1 ethanones? Chem J Moldova 2006,1(1),36-49","journal-title":"Chem J Moldova"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1021\/acs.jmedchem.8b00641","volume":"61","author":"Friggeri L.","year":"2018","unstructured":"Friggeri L.; Hargrove T.Y.; Wawrzak Z.; Blobaum A.L.; Rachakonda G.; Lindsley C.W.; Villalta F.; Nes W.D.; Botta M.; Guengerich F.P.; Lepesheva G.I.; Sterol 14\u03b1-Demethylase structure-based design of VNI ((R)- N -(1-(2,4-Dichlorophenyl)-2-(1 H -imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) derivatives to target fungal infections: Synthesis, biological evaluation, and crystallographic analysis. J Med Chem 2018,61(13),5679-5691","journal-title":"J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1016\/j.bmcl.2011.06.076","volume":"21","author":"Roy K.K.","year":"2011","unstructured":"Roy K.K.; Singh S.; Sharma S.K.; Srivastava R.; Chaturvedi V.; Saxena A.K.; Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H37RV. Bioorg Med Chem Lett 2011,21(18),5589-5593","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejmech.2015.08.020","volume":"102","author":"Jeong K.","year":"2015","unstructured":"Jeong K.; Lee J.; Park S.; Choi J.H.; Jeong D.Y.; Choi D.H.; Nam Y.; Park J.H.; Lee K.N.; Kim S.M.; Ku J.M.; Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD). Eur J Med Chem 2015,102,387-397","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejmech.2016.09.060","volume":"126","author":"Shaik S.P.","year":"2017","unstructured":"Shaik S.P.; Nayak V.L.; Sultana F.; Rao A.V.S.; Shaik A.B.; Babu K.S.; Kamal A.; Design and synthesis of imidazo[2,1-b]thiazole linked triazole conjugates: Microtubule-destabilizing agents. Eur J Med Chem 2017,126,36-51","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/app12010078","volume":"12","author":"Sim M.","year":"2021","unstructured":"Sim M.; Lee S.; Han Y.; Synthesis and structural confirmation of the thiazole alkaloids derived from Peganum harmala L. Appl Sci 2021,12(1),78","journal-title":"Appl Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/00397911.2020.1854787","volume":"51","author":"Ali S.H.","year":"2021","unstructured":"Ali S.H.; Sayed A.R.; Review of the synthesis and biological activity of thiazoles. Synth Commun 2021,51(5),670-700","journal-title":"Synth Commun"},{"key":"ref=35","year":"2021","unstructured":"LigPrep 2021","journal-title":"LigPrep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"Madhavi Sastry G.","year":"2013","unstructured":"Madhavi Sastry G.; Adzhigirey M.; Day T.; Annabhimoju R.; Sherman W.; Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 2013,27(3),221-234","journal-title":"J Comput Aided Mol Des"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"Friesner R.A.","year":"2006","unstructured":"Friesner R.A.; Murphy R.B.; Repasky M.P.; Frye L.L.; Greenwood J.R.; Halgren T.A.; Sanschagrin P.C.; Mainz D.T.; Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006,49(21),6177-6196","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"Halgren T.A.","year":"2004","unstructured":"Halgren T.A.; Murphy R.B.; Friesner R.A.; Beard H.S.; Frye L.L.; Pollard W.T.; Banks J.L.; Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004,47(7),1750-1759","journal-title":"J Med Chem"},{"key":"ref=39","year":"2019","unstructured":"QikProp 2019","journal-title":"QikProp"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/cber.188702002200","volume":"20","author":"Hantzsch A.","year":"1887","unstructured":"Hantzsch A.; Weber J.H.; Ueber verbindungen des thiazols (pyridins der thiophenreihe). Ber Dtsch Chem Ges 1887,20(2),3118-3132","journal-title":"Ber Dtsch Chem Ges"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230321145543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214829\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230321145543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T06:48:45Z","timestamp":1699598925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214829\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666230321145543","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}